Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
Saved in:
| Published in: | Haematologica - the Hematology journal |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301673395814401 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Haematologica - the Hematology journal |
| description | |
| discipline_display | Hematology |
| discipline_facet | Hematology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69087 |
| institution | FRELIP |
| journal_source_facet | Haematologica - the Hematology journal |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication Hematology General Hematology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Hematology General Hematology Hematology General Hematology |
| subject_facet | Hematology General Hematology |
| title | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_auth | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_full | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_fullStr | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_full_unstemmed | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_short | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_sort | multicenter upfront randomized phase ii trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with fmslike tyrosine kinase 3 internal tandem duplication |
| topic | Hematology General Hematology |
| url | https://haematologica.org/article/view/13000 |